Partnerships are critical to our success

Orexo has long experience in successful collaborations, which has enabled the development and launch of novel products, offering improved treatment options for patients worldwide.

We continuously evaluate new potential partnerships to grow our business and meet our goals. In-licensing of products, technologies or development projects which can complement our commercial strategy and out-licensing of our innovative project assets is of highest priority.

For questions regarding business development please contact:


Robert Coburn

Other countries

Petter Wereén, VP Procurement and Business Development


Orexos partners:

Providing commercialization of ZUBSOLV® in the EU

Accord Healthcare's website


Providning commercialization of Abstral® outside the US and EU, where patents have expired

Kyowa Kirin's website


Providing commercialization of Edluar® worldwide ex the US

Viatris' website


Development of OX-MPI

Gesynta Pharma's website


Development of MODIA®, vorvida® and deprexis® 

GAIA's website